Oscar Perez-Leal

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Venues

Biomolecules

Antioxidants (Basel, Switzerland)

Science translational medicine

Temple University

Temple University Fox School of Business and Management (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Temple University Jun 01 2014

United States

Assistant Professor :: Pharmaceutical Sciences

Education History

Temple University Fox School of Business and Management

United States

MSC

Universidad del Norte Jan 15 1996 - Dec 22 2002

Colombia

PHD

Publications

Harutyun Khachatryan, Bartlomiej Olszowy, Carlos A Barrero, John Gordon, Oscar Perez-Leal
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1. Biomolecules 13 (2) (2023)
Harutyun Khachatryan, Bartlomiej Olszowy, Carlos A Barrero, John Gordon, Oscar Perez-Leal
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1. Biomolecules 13 (2) (2023)
Mario C Rico, Oscar Perez-Leal, Mary F Barbe, Mamta Amin, Dennis J Colussi, Magda L Florez, Victor Olusajo, Dennise S Rios, Carlos A Barrero
Extracellular Acetylated Histone 3.3 Induces Inflammation and Lung Tissue Damage. Biomolecules 13 (9) (2023)
Harutyun Khachatryan, Bartlomiej Olszowy, Carlos A Barrero, John Gordon, Oscar Perez-Leal
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1. Biomolecules 13 (2) (2023)
Harutyun Khachatryan, Bartlomiej Olszowy, Carlos A Barrero, John Gordon, Oscar Perez-Leal
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1. Biomolecules 13 (2) (2023)
James Li, Sandra Arest, Bartlomiej Olszowy, John Gordon, Carlos A Barrero, Oscar Perez-Leal
CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease. Antioxidants (Basel, Switzerland) 12 (7) (2023)
Connor Quinn, Mario C Rico, Carmen Merali, Carlos A Barrero, Oscar Perez-Leal, Victoria Mischley, John Karanicolas, Scott L Friedman, Salim Merali
Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying TGFβ signaling in hepatic stellate cells. Science translational medicine 15 (715) (2023)

Oscar Perez-Leal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Oscar Perez-Leal